High integrity storage of larger sample volumes
![](/46/pdcnewsitem/03/84/22/micronicpr126-imageB.jpg)
Micronic has expanded its range of high quality 4.00 mL sample storage tubes to now include non-coded, alphanumeric and 2D data matrix coded formats.
Offering a working volume of 2.70 mL these tubes provide an ideal solution for storing larger volumes in a wide variety of short-term and long-term sample storage applications. Incorporating an internal thread screw cap with silicon O-ring, Micronic 4.00 mL tubes provide optimal sealing enabling high integrity storage at ultra-low temperatures. Benefiting from a flat bottom, Micronic 4.00 mL tubes also provide an ideal solution for transportation or storage of solid biological samples.
Precision manufactured from ultra-pure grade polypropylene, in a certified Class 7 clean room production environment, Micronic 4.00 mL tubes are available in bulk and in automation-compatible Micronic 48-4 Racks. This 48-well format rack features a laser etched 1D rack barcode on one side and 'Twist-Lock' to prevent tubes from turning during screw capping or decapping.
Micronic 4.00 mL tubes with a 2D Data-Matrix code permanently laser-etched on the bottom of the tube are the storage medium of choice for customers demanding long-term reliable code reading. The 4.00ml alphanumeric tubes are a great option for customers who just need to identify their samples visually. For labs requiring larger volume storage in a top quality tube, Micronic 4.00 mL non-coded tubes provide a cost-competitive solution.
To enhance visual identification of samples - Micronic screw caps for 4.00 mL tubes are available in 12 colours. In addition, Micronic screw caps are designed to be closed with a 'single turn' to ease opening and closure during manual processing.
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance